Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. - Wikidata - awgldk - TriplyDB

Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial.

Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial.

http://www.wikidata.org/entity/Q43910130

about

Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection Xylotubercidin against herpes simplex virus type 2 in mice Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes.Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases Chemotherapy for herpes simplex virus infections Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir.Antiviral therapy: current concepts and practices Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.Evaluation of the activity and safety of CS21 barrier genital gel® compared to topical aciclovir and placebo in symptoms of genital herpes recurrences: a randomized clinical trial.Antiherpes drugs: promises and pitfalls.Failure of topical acyclovir in ointment to penetrate human skin.ME-609: a treatment for recurrent herpes simplex virus infections.Long-term clinical and psychological management of genital herpes.Topical treatment of recurrent genital herpes infections with foscarnet.Evaluation of some pyrazoloquinolines as inhibitors of herpes simplex virus type 1 replication.

P2860

Q28360186-3864D0D9-6F27-42D1-B476-69AD5EEB8C24 Q28362158-11A53D9B-8317-4F55-8277-A822FE36D965 Q33582991-98AFBD14-8A5B-4F39-92B7-186869241753 Q33701865-512AD707-9A7F-4E29-8A65-3D5883903C00 Q33978415-E8AD45EE-59CF-4DAA-8CF6-F6AD3F3A17DA Q33980379-66A5B083-B7E3-486D-8A3F-F958EF00B266 Q33997400-7517C9DB-3493-470C-86C9-CA797785F707 Q34193041-997679F3-CA04-4C53-AFB4-44FC5A1106B3 Q35230156-B7C58EDE-6B05-423E-8B80-C8FE68162524 Q35759608-54E6D2DB-5EFF-459B-85F3-438D0840C127 Q36070394-391148BB-380C-49C3-8A1F-8EFE6A7A2DCA Q36170672-CC37E709-B2E7-434E-83AD-DC355B721CCB Q36823598-551A20A1-E4D7-49F3-962B-D880A9CBA9DC Q38497093-18F352EC-D7F4-49E3-9D83-37D54DC893C8 Q39220986-20319A8B-31BA-4E3F-A4A9-7662E34A5B0B Q40142222-F0B49CCF-9464-4F54-8230-627F0422A239 Q40283444-C8541FF7-C1E7-4C56-BDEB-395AF3F301DC Q40622196-991EB3E3-6AC9-40EB-83BB-BE9F669F7D27 Q40782524-FC2E79EB-6B6C-40FD-BDDA-52428C7759E2 Q44216977-EBA9B6B3-C64E-4423-AACD-77DEB7D82661 Q45286596-01D1E316-B93F-4418-B251-BD7F7EE180AA

P2860

Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial.

http://www.wikidata.org/entity/Q43910130

description

1983 nî lūn-bûn

@nan

1983年の論文

@ja

1983年学术文章

@wuu

1983年学术文章

@zh

1983年学术文章

@zh-cn

1983年学术文章

@zh-hans

1983年学术文章

@zh-my

1983年学术文章

@zh-sg

1983年學術文章

@yue

1983年學術文章

@zh-hant

name

Topically administered acyclov ...... genitalis: a controlled trial.

@en

Topically administered acyclov ...... genitalis: a controlled trial.

@nl

type

label

Topically administered acyclov ...... genitalis: a controlled trial.

@en

Topically administered acyclov ...... genitalis: a controlled trial.

@nl

prefLabel

Topically administered acyclov ...... genitalis: a controlled trial.

@en

Topically administered acyclov ...... genitalis: a controlled trial.

@nl

P1433

Q43910130-DD0ACB42-2F99-4E7D-BBCC-883B9939CAAA

P1476

Q43910130-252C34B7-496D-4D36-BD2D-377CCB716A51

P2093

Q43910130-21FD1D14-4997-4288-8434-B9143319053D

Q43910130-27DA6F83-0331-4472-B3F9-EF3476CAAC07

Q43910130-4AB39E46-7D1F-4E84-BDE6-3CF321162E5D

Q43910130-5B5F7F56-E444-4674-BCE8-A19D63B1FED0

Q43910130-85D3BDA2-223E-40E8-9904-2E3CE10EFA5C

Q43910130-AFEB6DF0-845A-4BB5-A21C-D5895451C9AE

Q43910130-BBEE1557-8E64-4500-899C-E58398E0CC65

Q43910130-BD279931-8DEC-4443-9969-3176AC311E12

P304

Q43910130-65687139-B17B-4BB1-8FFA-95F4E2B560B5

P31

Q43910130-14E7462A-01DB-465D-AA0D-3EA7332F6247

P356

Q43910130-9D2118FF-2372-4013-9021-A8D595408AC5

P407

Q43910130-75687249-3D99-451C-BA6D-506776EBDE8D

P433

Q43910130-77D55B41-CBE1-451B-BF57-6D2C9FD20491

P478

Q43910130-D3684F4D-25E5-4D94-B262-835F95C839CE

P577

Q43910130-1BA24AD7-5A1C-4FCD-BE66-4D88F9C95420

P698

Q43910130-07342209-16F1-4CA2-A2FF-4A59B6D12424

P356

P1433

The Journal of Infectious Diseases

P1476

Topically administered acyclov ...... genitalis: a controlled trial.

@en

P2093

Ashikaga T

http://www.w3.org/2001/XMLSchema#string

Badger GJ

http://www.w3.org/2001/XMLSchema#string

Davis LG

http://www.w3.org/2001/XMLSchema#string

Dolin R

http://www.w3.org/2001/XMLSchema#string

Guinan ME

http://www.w3.org/2001/XMLSchema#string

Keeney RE

http://www.w3.org/2001/XMLSchema#string

Nahmias AJ

http://www.w3.org/2001/XMLSchema#string

Reichman RC

http://www.w3.org/2001/XMLSchema#string

P304

336-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/147.2.336

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P577

1983-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6298318

http://www.w3.org/2001/XMLSchema#string